Dr. Ronald Irwin Jacobson is a Sleepy Hollow, New York based neurologist who is specialized in Child Neurology. His current practice location is 755 North Broadway, Medical Services Building Suite 540, Sleepy Hollow. Patients can reach him at 914-358-0190 or can fax him at 914-358-0199. Dr. Ronald Irwin Jacobson is MD in Child Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1164519120. Dr. Ronald Irwin Jacobson specializes in neurology with special skills in diagnosis and treatment of neurologic disorders of the neonatal period, infancy, early childhood, and adolescence.
Complete Profile:
Dr. Ronald Irwin Jacobson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Ronald Irwin Jacobson
Specialization:
Child Neurology
Gender:
Male
Credentials:
MD
Practice Address:
755 North Broadway, Medical Services Building Suite 540, Sleepy Hollow, New York, 10591
Phone:
914-358-0190
Fax:
914-358-0199
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1164519120
NPI Enumeration Date:
09 Oct, 2006
NPI Last Update On:
18 Apr, 2008
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Ronald Irwin Jacobson 755 North Broadway, Medical Services Building Suite 540 Sleepy Hollow, New York
Zip:
10591
Phone Number:
914-358-0190
Fax Number:
914-358-0199
Patients can reach Dr. Ronald Irwin Jacobson at 755 North Broadway, Medical Services Building Suite 540, Sleepy Hollow, New York or can call to book an appointment on 914-358-0190.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.